Sys2Diag - Umr9005 Cnrs/Alcen
Montpellier, 34184, France
Location contact
Franck MOLINA, Phd
CONTACT
Laurence MOLINA, PhD
PRINCIPAL_INVESTIGATOR
Malik KAHLI, PhD
SUB_INVESTIGATOR
Wendpouiré A OUEDRAOGO, Msc
CONTACT
NCT Number: NCT07507266
Architecture influences our well-being. People's behavior and mood changes in different spaces are directly related to the architectural qualities of the built environment. Neuroarchitecture is a discipline that combines neuroscience and architecture to design spaces adapted to the psychological and physiological needs of users. Several studies related to neuroarchitecture have been conducted according to different architectural parameters such as style, natural environment, lighting, color, and sunlight pattern. Recent studies show that emotional states can be evaluated by physiological responses. This physiological regulation comes from the action of enzymes and hormones that represent the activity of the autonomic nervous system. Measuring specific biomarkers through non-invasive biological tests in saliva provides physiological data on an individual's emotional state in response to stimuli, particularly visual or tactile.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Montpellier, 34184, France
Franck MOLINA, Phd
CONTACT
Laurence MOLINA, PhD
PRINCIPAL_INVESTIGATOR
Malik KAHLI, PhD
SUB_INVESTIGATOR
Wendpouiré A OUEDRAOGO, Msc
CONTACT
Architecture influences our well-being, and people's behavior and mood changes in different spaces are directly related to the architectural qualities of the built environment. For example, noise and lack of vegetation can generate stress and stress associated with the built environment can even negatively impact life expectancy. Moreover, psychology, and more specifically emotional regulation, plays a fundamental role in how individuals perceive and react to their environment. Emotional regulation is closely linked to the attachment style developed during childhood. Studies have shown that insecure attachment is associated with poorer emotional regulation, which can amplify stress reactions in response to an environment perceived as hostile or inadequate. Neuroarchitecture is a discipline that combines neuroscience and architecture to design spaces adapted to the psychological and physiological needs of users. Its main objective is to create environments that positively influence emotions and well-being, taking into account how our brain perceives and reacts to different elements of space. Several studies related to neuroarchitecture have been conducted according to different architectural parameters such as style, natural environment, lighting, color, and sunlight pattern. These studies generally use tools such as self-assessment scales (e.g., PANAS for affect), functional magnetic resonance imaging (fMRI), electroencephalogram (EEG), and heart rate measurement. These often subjective or indirect methods require trained and/or medical personnel and heavy equipment. In addition, emotions and their regulation are influenced by several sociodemographic factors, including age and the development of the prefrontal cortex, but also gender, socioeconomic level, education level, and cultural context. These factors modulate exposure to stress, the available regulation strategies, and their effectiveness. Life history, particularly early exposure to traumatic events, is also determining. These elements justify the attention paid to inclusion and exclusion criteria in the study (particularly age, gender, cultural context, etc.) to best control these variables. Recent studies show that emotional states (positive and negative) can also be evaluated by physiological responses. This physiological regulation comes from the action of enzymes and hormones that represent the activity of the autonomic nervous system. Thus, several studies using the Trier Social Stress Test (TSST) have highlighted an increase in the concentration of cortisol, DeHydroEpiAndrosterone (DHEA), and salivary alpha-amylase in response to a state of acute stress and anxiety in tested individuals. Glenk et al. studied 40 adults (21 to 34 years old, allergic or not) using measures such as the State-Trait Anxiety Inventory (STAI-S) (20 self-reported items), the Emotion Regulation Questionnaire (ERQ), a visual analog scale of perceived stress (VAS), salivary cortisol measurements, and plasma oxytocin. Izawa et al. analyzed salivary DHEA levels, blood pressure, and heart rate in 33 students with an average age of 22. Van Stegeren et al. measured salivary cortisol and alpha-amylase in 80 adults (men and women) exposed to TSST. Furthermore, an association between positive emotions and a decrease in salivary cortisol has also been described by Lai et al. in 80 adults via a questionnaire and salivary cortisol analysis. Oxytocin modulates the integration of emotional information and interacts with the reward pathway. It is released during positive social interactions and can downregulate stress and heart rate (study of 163 young adults under 35, high school level, no medication, questionnaires, filmed interviews, blood oxytocin measurement). Finally, Kanen et al. showed that fluctuations in serotonin concentration can generate various emotional phenotypes, highlighting the neurobiological impact on emotional regulation. It is therefore essential that participation in architectural exposure is voluntary, as the perception of control is a key factor in modulating the emotional response. Finally, measuring specific biomarkers (enzymes, hormones) through non-invasive biological tests in saliva provides reliable physiological data on an individual's emotional state). These approaches have already been applied to analyze the effects of olfactory stimuli (study of 170 participants, questionnaires, and salivary biomarkers) or architectural. The objective of the proposed research is therefore to measure, in an immersive context (architecture festival), salivary molecular biomarkers known to be linked to emotions. These measurements are intended to objectively measure the influence of an architectural context on physiological parameters related to emotions, while taking into account the psychological, sociodemographic, and developmental factors identified through a dedicated questionnaire.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Saliva of participants will be sampled for analysis of biomarkers of interest (DHEA, oxytocin, cortisol, alpha-amylase, serotonin, and dopamine) using enzymatic dosage methods or ELISA-type methods carried out using commercial kits.
Time frame: 2 years
Evaluate the variation of salivary biomarkers, which may be linked to emotions (positive or negative), before and after interaction with an architectural work. This exposure includes a combination of visual, tactile, and/or olfactory stimuli.
Time frame: 2 years
Identify, from measurements of alpha-amylase, cortisol, DHEA, oxytocin, serotonin, and dopamine, one or more profile(s) of biomarker concentration variation, which would differentiate the emotions felt following exposure to an architectural site. These combinations of biomarkers could identify an emotion profile linked to a biomarker signature.
Time frame: 2 years
Compare the different combinations of biomarker variations identified previously according to the two studied architectural sites. Indeed, since the two sites are architecturally different, the identified signatures could be different depending on the sites.
Time frame: 2 years
Compare the biomarker signatures measured after stimulation and the sociodemographic and developmental data to establish correlations between the stimuli, the emotions felt, and age, gender, etc.
Time frame: 2 years
Analyze the dispersion of the data obtained for each architectural site according to the day, age, gender, etc.
Contact information is provided by the study sponsor or research team.
Sys2Diag
Other Gov
Evaluation of Emotions From Salivary Molecular Biomarkers in an Architectural Context
Acronym: Archi'Motion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06806150
Behavior, Behavioral Symptoms
Bern, Switzerland
View Trial DetailsNCT06827028
Anxiety, Anxiety Disorders
Munich, Bavaria, Germany
View Trial DetailsNCT06071130
Aging, Behavior
Chicago, Illinois, United States
View Trial DetailsNCT06158880
Alcohol Drinking, Behavior
Phoenix, Arizona, United States
View Trial Details